https://www.selleckchem.com/pr....oducts/rxdx-106-cep-
Atypical hemolytic uremic syndrome (aHUS) is characterized by microangiopathic hemolytic anemia, thrombocytopenia and kidney injury caused by a dysregulation of the alternative complement pathway. We conducted a multicenter nonregistry study aimed at collecting clinical, laboratory and genetic information of patients with aHUS in Brazil. Demographic data, genetic findings, treatments and outcomes are presented. Thirty-four patients were included, 62% were female and 67% were Caucasian. Half of the patients had the first manif
Like
Comment
Share
